Cyclophosphamide-induced changes in the mouse: Effects upon cellular composition, immune function, and disease
- 1 January 1984
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 30 (1), 51-61
- https://doi.org/10.1016/0090-1229(84)90006-0
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- A spontaneous rheumatoid arthritis-like disease in MRL/l mice.The Journal of Experimental Medicine, 1982
- Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene.The Journal of Experimental Medicine, 1981
- Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2.The Journal of Experimental Medicine, 1981
- Distribution of lymphocytes identified by surface markers in murine strains with systemic lupus erythematosus-like syndromes.The Journal of Experimental Medicine, 1979
- Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.The Journal of Experimental Medicine, 1975
- Therapeutic studies in NZB/W MICEArthritis & Rheumatism, 1975
- Activation of cyclophosphamide in man and animalsCancer, 1971
- CYCLOPHOSPHAMIDE TREATMENT OF RENAL DISEASE IN (NZB × NZW) F1 HYBRID MICEThe Lancet, 1968
- CYCLOPHOSPHAMIDE TREATMENT OF KIDNEY DISEASE IN (NZB X NZW) F1 MICEThe Lancet, 1966
- Studies on the mechanism of action of cyclophosphamide and AB-132 with the aid of radioprotective agentsLife Sciences, 1964